Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Assesment of perforin expression in peripheral blood lymphocytes in psoriatic patients during exacerbation of disease (CROSBI ID 95861)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Prpić, Larisa ; Štrbo, Nataša ; Sotošek, Vlatka ; Gruber, Franjo, Podack, Eckhard R. ; Rukavina, Daniel Assesment of perforin expression in peripheral blood lymphocytes in psoriatic patients during exacerbation of disease // Acta dermato-venereologica, 211 (2000), 14-16

Podaci o odgovornosti

Prpić, Larisa ; Štrbo, Nataša ; Sotošek, Vlatka ; Gruber, Franjo, Podack, Eckhard R. ; Rukavina, Daniel

engleski

Assesment of perforin expression in peripheral blood lymphocytes in psoriatic patients during exacerbation of disease

There are very few data concerning the role played by cell-mediated cytotoxicity, particularly at the molecular level, in the course of psoriasis. Both cytotoxic T lymphocytes (CTL) and antural killer cells contain in their granules the cytolytic protein perforin, a mediator in cell-mediated cytotoxicity reactions. The aim of this study was to analyze perforin expression in various sets and subsets of perforin-positive peripheral blood lymphocytes in 17 patients with chronic psoriasis vulgaris in the exacerbation phase. The results were compared with those of an age- and sex- matched healthy control group (n=21). Perforin (intracellular antigen) and cell surface antigens were detected using the simultaneous double- staining method. We found a significant increase in perforin (P) expression in the patient group for CTL (CD3+P+ cells), which are located mostly in the CD8+ population of T lymphocytes (CD8+P+).

Psoriasis ; Perforin ; Cytotoxic T lymphocytes ; NK cells

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

211

2000.

14-16

objavljeno

0001-5555

1651-2057

Povezanost rada

Farmacija, Kliničke medicinske znanosti

Indeksiranost